IMI Pain-Care:
IMI-PainCare is a large multi-stakeholder consortium funded via the Innovative Medicines Initiative 2 programme, which receives funding from the European Commission and the pharmaceutical industry. IMI-PainCare aims to develop alignment on patient reported outcomes used in pain research, identification of biomarkers for pain, and the refinement of preclinical models for improved translational pain research.
INTERACT-EUROPE:
INTERACT-EUROPE is an 18-month project (July 2022 – November 2023) co-funded by the EU under the EU4Health programme 2021-2027 as part of Europe’s Beating Cancer Plan. The European Cancer Organisation is co-ordinating this project that brings together 33 partners from 17 countries aiming at developing a European inter-specialty cancer training programme involving all main oncology disciplines and professions, cancer centres and patient groups, based on relevant needs assessments.
Watch this video to find out more about the project.
PANACEA:
PANACEA is a three-year project funded under the European Erasmus+ programme and aims to contribute to reducing the gap between placebo/nocebo scientific evidence and clinical practice of the future, i.e., higher education students in medicine and nursing, and of today healthcare professionals.
Find out more in this presentation.
Comorbidity of cHronic Pain and mood disorders: breaking the vicious cYcle (HaPpY):
HaPpY is a Marie Skłodowska-Curie Innovative Training Network funded via the European Commission’s Horizon 2020 budget. HaPpY aims to create an optimal environment for the training of Early Stage Researchers (ESRs) to break the vicious cycle linking chronic pain and mood disorders. Participate in our webinar 17 November 2022 at 3pm CET to find out more about the HaPpY project.
